It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Discover Weekly Automatic Buy Dividend Aristocrats Etf to set up a disciplined, recurring purchase schedule that smooths classic market timing.
14,755 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Costco posted solid June numbers, with a 10.6% rise in sales and a strong e-commerce lift. Yet the stock declined, si...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
As pepsico (pep) 2026 earnings shape the near-term outlook, investors want clarity on growth drivers, costs, and capi...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...
Looking for steady income in a volatile market? This guide highlights three high-yield energy stocks march investors ...
A fresh pullback can create smart entry points. This guide highlights my top 3 financial stocks after latest market p...
Strategy, led by Michael Saylor, plans to fund STRC dividends by selling Bitcoin, with a long-term goal to buy more B...
Treasury yields are climbing, sending ripples through equities. This piece breaks down why rates are rising, who’s af...
As market focus shifts away from growth labels, three legacy automakers stand out for retirees seeking cash flow and ...
IBM rallied today on a blend of solid earnings, growing cloud demand, and quantum computing momentum backed by govern...